Table 1 Baseline characteristics
Variable | ATC (n = 257) | Standard (n = 263) |
|---|---|---|
Age (yr) | 66.6 ± 8.6 | 65.9 ± 10.8 |
Male | 203 (79) | 206 (78) |
Body mass index (kg/m2) | 30.0 ± 5.4 | 29.4 ± 5.6 |
LVEF | 60.0 (50.0;60.0) | 60.0 (50.0;65.0) |
Arterial hypertension | 208 (81) | 213 (81) |
Diabetes mellitus | 113 (44) | 97 (37) |
Coronary artery disease | 228 (87) | 228 (89) |
Peripheral arterial disease | 48 (19) | 38 (14) |
COPD | 48 (19) | 42 (16) |
Dyslipidemia | 217 (84) | 209 (80) |
NYHA ≥ III | 56 (22) | 44 (17) |
Unstable angina | 60 (23) | 69 (26) |
Recent MI | 78 (30) | 78 (30) |
Chronic kidney disease stage ≥3 | 31 (12) | 39 (15) |
Medication | ||
Aspirin | 222 (86) | 222 (84) |
Warfarin | 3 (1) | 4 (2) |
IV Heparin | 84 (33) | 94 (36) |
Discontinued antiplatelet therapy | 53 (21) | 65 (25) |
EuroSCORE II (%) | 1.69 (1.00;2.73) | 1.58 (1.11;2.82) |